SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context
14 references·1 citing·49 second hop
Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context (2012)Value-Based Differential Pricing: Efficie…Drug Pricing and Value in Oncology (2010)Drug Pricing and Value in Onc…An Economic Justification for Open Access to Essential Medicine Patents in Developing Countries (2009)An Economic Justification for…Value based pricing for NHS drugs: an opportunity not to be missed? (2008)Value based pricing for NHS d…Innovation and the welfare effects of public drug insurance (2008)Innovation and the welfare ef…Cost-effectiveness analysis and innovation (2008)Cost-effectiveness analysis a…Insurance and Incentives for Medical Innovation (2006)Insurance and Incentives for …Parallel trade, price discrimination, investment and price caps (2005)Parallel trade, price discrim…Parallel Trade, International Exhaustion and Intellectual Property Rights: A Welfare Analysis (2005)Parallel Trade, International…Optimal Departures from Marginal Cost Pricing (2005)Optimal Departures from Margi…Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents (2003)Differential Pricing for Phar…Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU (1997)Price Discrimination for Phar…Parallel imports, demand dispersion, and international price discrimination (1994)Parallel imports, demand disp…A Contribution to the Theory of Taxation (1927)A Contribution to the Theory …General Equilibrium Computations of the Marginal Welfare Costs of Taxes in the United States.General Equilibrium Computati…Global Health Impact (2020)Global Health ImpactThe Economics of Imperfect Competition. (1934)Allocative efficiency vs. X-Efficiency (1966)Differential Taxation, Public Goods, and Economic Efficiency (1971)On the theory of tax reform (1976)The theory of peak-load pricing: A survey (1995)Using Value of Information Analysis to Prioritise Health Research (2006)Exploring Uncertainty in Cost-Effectiveness Analysis (2008)Subgroups and Heterogeneity in Cost-Effectiveness Analysis (2008)Examining the Use of Real‐World Evidence in the Regulatory Process (2019)A Theory of Incentives in Procurement and Regulation (1993)A theory of incentives in procurement and regulation (1994)The Economics of Parallel Trade (1998)Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand (2003)Price regulation and parallel imports of pharmaceuticals (2015)Does Public Insurance Crowd out Private Insurance? (1996)Patent Buy-Outs: A Mechanism for Encouraging Innovation (1997)Tax Avoidance and the Deadweight Loss of the Income Tax (1999)Health insurance as a two-part pricing contract (2013)HOW DOES PATENT LITIGATION INFLUENCE DYNAMIC RISK FOR MARKET COMPETITORS? (2015)Did Medicare Part D reduce mortality? (2017)A ‘reciprocal dumping’ model of international trade (1983)The Theory of Industrial Organization (1988)Theory of Industrial Organization. (1989)The Evolution of Price Dispersion in the European Car Market (2001)Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement (2013)Cost-Effectiveness in Health and Medicine (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)Intellectual Property, Information Technology, Biomedical Research, and Marketing of Patented Products (2011)That’s What Friends Are For: Adolescent Peer Social Status, Health-Related Quality of Life and Healthcare Costs (2014)The insurance value of medical innovation (2016)Property Rules, Liability Rules, and Inalienability: One View of the Cathedral (1972)A New Data Set Measuring Income Inequality (1996)Squaring the Circle: AIDS, Poverty, and Human Development (2007)GLOBAL HEALTH IMPACT: A BASIS FOR LABELING AND LICENSING CAMPAIGNS? (2012)Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues (2018)The Right to Medicines in an Age of Neoliberalism (2019)The Pure Theory of Public Expenditure (1954)The Incidence of the Corporation Income Tax (1962)An Aging Society: Opportunity or Challenge? (1990)Chapter 25 Government debt (1999)Monitoring Corruption: Evidence from a Field Experiment in Indonesia (2005)Optimal Taxation and Public Production I: Production Eficiency (2016)The price of innovation: new estimates of drug development costs (2003)Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II (2009)Investments in Pharmaceuticals Before and After TRIPS (2011)How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries (2017)Health insurance and the demand for medical care: evidence from a randomized experiment. (1987)Signaling in Retrospect and the Informational Structure of Markets (2002)Salience and Taxation: Theory and Evidence (2009)
this work references cited by second hop

References

  • 1927A Contribution to the Theory of Taxation2,918 cited
  • 2005Optimal Departures from Marginal Cost Pricing929 cited
  • n.d.General Equilibrium Computations of the Marginal Welfare Costs of Taxes in the United States.650 cited
  • 2003Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents317 cited
  • 1994Parallel imports, demand dispersion, and international price discrimination258 cited
  • 2008Value based pricing for NHS drugs: an opportunity not to be missed?230 cited
  • 1997Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU122 cited
  • 2008Cost-effectiveness analysis and innovation110 cited
  • 2009An Economic Justification for Open Access to Essential Medicine Patents in Developing Countries106 cited
  • 2008Innovation and the welfare effects of public drug insurance81 cited
  • 2006Insurance and Incentives for Medical Innovation64 cited
  • 2005Parallel trade, price discrimination, investment and price caps62 cited
  • 2010Drug Pricing and Value in Oncology61 cited
  • 2005Parallel Trade, International Exhaustion and Intellectual Property Rights: A Welfare Analysis19 cited

Cited by

  • 2020

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Global Health Impact
52 cited